RxDoctor Payments Data

Reid Castellone, MD

Family Medicine · Ninety Six, SCNPI 1154708543

Payments from drug & device makers

$7,533in general payments, 2019–2025

Across 461 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$677
  • AstraZeneca$578
  • GSK$563
  • Pfizer$532
  • Lilly USA, LLC$462
  • AbbVie$369
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$7,533100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk43$677
AstraZeneca28$578
GSK40$563
Pfizer40$532
Lilly USA, LLC33$462
AbbVie(2 entities)25$369
Johnson & Johnson23$317
Sanofi-aventis U.S. LLC18$261
Supernus Pharmaceuticals, Inc.6$258
Novartis14$255
Teva Pharmaceuticals USA, Inc.8$212
Amgen11$201
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$174
Takeda Pharmaceuticals U.S.A., Inc.10$173
E.r. Squibb & Sons, L.L.C.11$158
Esperion Therapeutics, Inc.10$154
Boehringer Ingelheim9$137
Sunovion Pharmaceuticals Inc.8$132
Merck9$125
Otsuka America Pharmaceutical, Inc.6$109
Astellas Pharma US Inc6$106
Exact Sciences6$103
Shire North American Group Inc7$102
Boston Scientific7$98
Phathom Pharmaceuticals, Inc.7$96
Alnylam Pharmaceuticals Inc.4$71
Bayer4$69
Eisai Inc.5$66
Antares Pharma, Inc.4$61
Medtronic3$58
Amarin Pharma, Inc.4$53
Peerless Surgical Inc.1$48
Arbor Pharmaceuticals, Inc.3$47
Jazz Pharmaceuticals Inc.2$47
Philips North America LLC2$46
Edwards Lifesciences2$43
Mylan Specialty L.p.3$42
Ironwood Pharmaceuticals, Inc2$38
Inari Medical, Inc.1$32
Globus Medical1$30
Sumitomo Pharma America, Inc.1$29
Intuity Medical Inc1$26
Dexcom, Inc.1$24
Urovant Sciences Inc1$24
Abbott1$23
Nestle Healthcare Nutrition Inc.1$22
OWP Pharmaceuticals, Inc.1$22
Aytu Biopharma, Inc.1$21
Bausch Health US, LLC1$21
Organon1$18
Neurocrine Biosciences, Inc.1$18
Lundbeck LLC1$18
Biohaven Pharmaceuticals, Inc.1$16
Biohaven Pharmaceutical Holding Company Ltd.1$15
Biodelivery Sciences International, Inc.1$15
Corcept Therapeutics1$15
Hikma Pharmaceuticals USA1$15
Tolmar, Inc.1$15
Kowa Pharmaceuticals America, Inc.1$13
Acerus Pharmaceuticals Corporation1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,533 in reported general payments places this provider in the 90th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$178,983
Medicare patients
427
Services billed
4,275

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide76$111,741
EliquisApixaban119$109,594
MounjaroTirzepatide99$99,323
JardianceEmpagliflozin66$94,970
JanuviaSitagliptin Phosphate32$27,450
MyrbetriqMirabegron43$24,283
EntrestoSacubitril/Valsartan12$16,694
LinzessLinaclotide15$16,293
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$14,226
RybelsusSemaglutide12$13,937
Tresiba Flextouch U-200Insulin Degludec19$12,679
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$11,934
FarxigaDapagliflozin Propanediol12$10,653
Combivent RespimatIpratropium/Albuterol Sulfate15$9,255
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr19$9,005

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$677$125,67988 claims
PfizerEliquis, Paxlovid$532$112,321132 claims
Boehringer IngelheimJardiance, Combivent Respimat$137$104,22581 claims
Lilly USA, LLCMounjaro$462$99,32399 claims
MerckJanuvia$125$27,45032 claims
AstraZenecaBreztri Aerosphere, Farxiga$578$24,87937 claims
Astellas Pharma US IncMyrbetriq$106$24,28343 claims
GSKTrelegy Ellipta, Anoro Ellipta$563$20,93938 claims
NovartisEntresto$255$16,69412 claims
AbbVieLinzess$369$16,29315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Ninety Six

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →